1. Home
  2. BLTE vs OR Comparison

BLTE vs OR Comparison

Compare BLTE & OR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$129.67

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Logo Osisko Gold Royalties Ltd

OR

Osisko Gold Royalties Ltd

N/A

Current Price

$30.30

Market Cap

6.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
BLTE
OR
Founded
2018
2014
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.1B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BLTE
OR
Price
$129.67
$30.30
Analyst Decision
Strong Buy
Buy
Analyst Count
9
11
Target Price
★ $233.00
$43.50
AVG Volume (30 Days)
142.0K
★ 881.9K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
★ 0.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$40.08
Revenue Next Year
N/A
$15.55
P/E Ratio
★ N/A
$55.77
Revenue Growth
N/A
N/A
52 Week Low
$115.41
$27.54
52 Week High
$200.00
$48.06

Technical Indicators

Market Signals
Indicator
BLTE
OR
Relative Strength Index (RSI) 32.18 34.80
Support Level N/A $27.54
Resistance Level $158.76 $37.28
Average True Range (ATR) 9.11 1.28
MACD -1.46 -0.45
Stochastic Oscillator 19.04 2.13

Price Performance

Historical Comparison
BLTE
OR

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About OR Osisko Gold Royalties Ltd

OR Royalties Inc is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.

Share on Social Networks: